0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 1152 results.
The global Bevacizumab Monoclonal Antibody Biosimilar market size is projected to grow from US$ 1311.8 million in 2022 to US$ 419.1 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Epogen and Biosimilar market size is projected to grow from US$ 699.4 million in 2022 to US$ 554.3 million in 2029; it is expected to grow...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Thyrogen and Biosimilar market size is projected to grow from US$ 251.4 million in 2022 to US$ 721.6 million in 2029; it is expected to...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Avastin (Bevacizumab) is a medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Enbrel (Etanercept) Biosimilar market size is projected to grow from US$ 1219.9 million in 2022 to US$ 1688.2 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Lucentis (Ranibizumab) and Biosimilar market size is projected to grow from US$ 1099.6 million in 2022 to US$ 910.1 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Enbrel (Etanercept) and Biosimilar market size is projected to grow from US$ 6211.9 million in 2022 to US$ 7862.4 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Infliximab Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (...
Catalog:
GIR
March 2023
Price: USD 4,480.00
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the '...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Neulasta (Pegfilgrastim) and Biosimilar market size was valued at USD 2501.4 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
